Archived News Headlines
We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.
Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.
SciClone Halts Study of Pancreatic Cancer Treatment
(Bloomberg) Oct 2, 2009 - SciClone Pharmaceuticals Inc. said it has discontinued a study of its experimental drug for pancreatic cancer after a recommendation by a safety review committee.
read article 
Peregrine Pharmaceuticals Reports Positive Results From Phase II Bavituximab Lung Cancer Trial
(MSN Money) Oct 5, 2009 - Peregrine Pharmaceuticals, Inc. today reported additional positive results in its Phase II trial evaluating bavituximab in combination with carboplatin and paclitaxel in patients with non-small cell lung cancer (NSCLC).
read article
ArQule Provides Clinical Update on ARQ 197 Enrollment Completed in Phase 2 Trial in Non-Small Cell Lung Cancer
(CNBC.com) Oct 5, 2009 - Enrollment begins in Phase 2 trial in hepatocellular carcinoma Second graph, second sentence of release should read: Final data from this trial is expected to be available in the first half of 2010. (sted 2009).
read article
Molecular Insight Pharmaceuticals Presents Azedra(TM) 12-Month Efficacy Data From Phase I Clinical Trial in Neuroendocrine Tumors
(Yahoo! Finance) Oct 5, 2009 - Molecular Insight Pharmaceuticals, Inc. today reported one-year follow-up data from a Phase I dose-escalation clinical study of Azedra(TM) demonstrating a positive safety profile and durable objective tumor responses in patients with neuroendocrine cancers, pheochromocytoma and paraganglioma.
read article
Inovio Biomedical Therapeutic Cervical Cancer Vaccine Demonstrates Safety and Immunogenicity in Clinical Trial
(CNBC.com) Oct 5, 2009 - Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today interim safety and immunogenicity data from its therapeutic cervical cancer vaccine (VGX-3100) trial.
read article
New Antibodies May Fight Child Cancer, Study Shows
(Reuters) Oct 4, 2009 - British scientists said on Monday they had developed potential new antibody treatments that could "super charge" the body's immune system to help it fight some types of cancer.
read article
Allos Therapeutics' Cancer Drug Folotyn Now for Sale
(Denver Business Journal) Oct 5, 2009 - Allos Therapeutics Inc. said Monday its cancer drug Folotyn, which the U.S. Food and Drug Administration approved last month, is now for sale in the United States.
read article
Texas Begins $3 Billion Quest to Cure Cancer
(ABCNews.com) Oct 2, 2009 - Texas gave birth to the modern oil industry, invented the handheld calculator and sent man to the moon. But can the Lone Star State cure cancer?
read article
FCP Raises Funds for Medical Research Center
(Washington Post) Oct 2, 2009 - Federal Capital Partners, a Georgetown private-equity firm, has led an effort to raise $70 million to build a research facility in Frederick for the National Cancer Institute, a rare feat amid a down market for construction financing.
read article (free registration required)
HealthCare Insight Announces Launch of New Cancer Management Service, OncologyClaim Insight(TM)
(Yahoo! Finance) Oct 5, 2009 - HealthCare Insight, a division of Verisk Health, Inc., and a provider of clinically validated fraud, abuse, and overpayment prevention solutions for private and public-sector payors, announced today the release of a new care management program for oncology claims.
read article
Cookbook Helps Make Food Appetizing for Cancer Patients
(CNN.com) Oct 5, 2009 - Walk into Lisa Nasser's kitchen most evenings and you're greeted by rich aromas that indicate an exceptional cook is at work on a delicious creation.
read article
A Look At Health Care Plans In Congress
(TheStreet.com) Oct 2, 2009 - Health care legislation is taking shape in the House and Senate as President Barack Obama pushes to overhaul the system to cover millions of uninsured Americans and contain rising costs.
read article
Two Democrats Withholding Support for Health Care Bill
(Boston Globe) Oct 5, 2009 - At least two Democrats on the Senate Finance Committee have refused to pledge support for the health care reform bill scheduled for a vote this week, underscoring the hard work ahead for President Obama as he tries to enact the most ambitious domestic policy legislation in more than a generation.
read article (free registration required)
Medical-Device Makers Push to Cut New Fees in Health Bill
(Wall Street Journal) Oct 5, 2009 - Medical-device makers, joining an 11th-hour scramble to influence the shape of health-care legislation in the Senate Finance Committee, have petitioned panel chairman Max Baucus to shave billions of dollars in fees that the industry would face under the measure.
read article (paid subscription required)
How Health Care Overhaul Could Change Medicare
(USA Today) Oct 3, 2009 - Businessman Stewart Grill, 75, believes there's waste in Medicare. He's just skeptical Congress can find and eliminate it without touching what he likes about his government health care plan.
read article
AstraZeneca: Onglyza EU Marketing Authorisation
(CNNMoney.com) Oct 5, 2009 - AstraZeneca PLC, a pharmaceutical company, and Bristol-Myers Squibb Company, a bio-pharmaceutical company, announced Monday that the European Commission has granted marketing authorisation for ONGLYZA (saxagliptin) in the 27 countries of the European Union.
read article
As TV Drug Ads Increase, So Do Concerns
(BusinessWeek.com) Oct 4, 2009 - You can't channel surf at all these days without stumbling across drug advertisements featuring happy people, sunny days, vague descriptions and a quickly mumbled list of side effects.
read article
Two Phase III Studies of Lucentis Show Early and Sustained Improvement in Vision in Patients with Retinal Vein Occlusion
(Yahoo! Finance) Oct 5, 2009 - Genentech, Inc., a wholly-owned member of the Roche Group, today announced results from two Phase III studies of Lucentis® (ranibizumab injection) in macular edema due to retinal vein occlusion (RVO), which showed, on average, patients given either of two doses of Lucentis had a clinically and statistically significant improvement in vision as measured by the primary endpoint of mean change from baseline in best-corrected visual acuity (BCVA) at six months compared to patients receiving sham injections.
read article
Bayer Labels’ Cancer-Fighting Claim Draws Suit
(New York Times) Oct 1, 2009 - A nonprofit group in Washington has filed a lawsuit against Bayer Healthcare charging that the company’s labels and commercials falsely claimed its One A Day multivitamins for men may reduce the risk of prostate cancer.
read article (free registration required)
Telik Says Early-stage Trial Data of Lung Cancer Drug Positive
(Reuters) Oct 1, 2009 - Telik Inc said its drug candidate Telcyta showed positive results in an early-stage trial as a combination therapy for non-small cell lung cancer patients, sending its shares up as much as 33 percent in after-market trade.
read article
Oncolytics Stock Soars on Cancer Trial Plan
(Reuters) Oct 2, 2009 - Oncolytics Biotech Inc said on Friday that it plans to work with the U.S. Food and Drug Administration to design a late-stage trial for its cancer treatment, sending its shares to a three-year high.
read article
UK's NICE Recommends Use Of GlaxoSmithKline's Hycamtin
(CNNMoney.com) Oct 2, 2009 - Drug maker GlaxoSmithKline PLC Friday said the U.K.'s National Institute for Health and Clinical Excellence recommended the use of its drug Hycamtin for patients whose lung cancer has returned.
read article
NEDD9 Protein Supports Growth of Aggressive Breast Cancer
(Fox Chase) Oct 2, 2009 – Researchers at Fox Chase Cancer Center have demonstrated that a protein called NEDD9 may be required for some of the most aggressive forms of breast cancer to grow.
read press release
Intensity and Timing of Physical Activity in Relation to Postmenopausal Breast Cancer Risk: The Prospective NIH-AARP Diet and Health Study
(BMC Cancer) Oct 1, 2009 - Despite strong evidence of an inverse association of physical activity with postmenopausal breast cancer risk, whether a certain intensity or time of life of physical activity is most effective for lowering breast cancer risk is not known.
read article
Molecular Imaging Holds Promise for Early Intervention in Common Uterine Cancer
(SNM) Sept 25 , 2009 - A promising new molecular imaging technique may provide physicians and patients with a noninvasive way to learn more information about a type of cancer of the uterus lining called “endometrial carcinoma”—one of the most common malignant female tumors.
read press release